| 2024/07/17 08:18:59 | |
|---|---|
| Price | |
| 2.525 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | NL0012047823 |
| Symbol | AVTX |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 202 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 2.515 EUR (750) |
| Ask (Ask size) | 2.525 EUR (750) |
| Open | 2.525 EUR |
| High | 2.525 EUR |
| Low | 2.525 EUR |
| Close (prev. day) | 2.525 EUR |
| VWAP | 2.105 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: AVANTIUM NV |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/17 08:18:59 | |
|---|---|
| Price | |
| 2.525 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | NL0012047823 |
| Symbol | AVTX |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 202 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 2.515 EUR (750) |
| Ask (Ask size) | 2.525 EUR (750) |
| Open | 2.525 EUR |
| High | 2.525 EUR |
| Low | 2.525 EUR |
| Close (prev. day) | 2.525 EUR |
| VWAP | 2.105 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -15.92% | -15.09% | -35.39% |
| Perf (abs.) | -0.48 | -0.45 | -1.38 |
| Beta | 0.65 | 0.76 | 0.98 |
| Volatility | 57.48 | 48.82 | 46.20 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.525 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 2.560 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 2.452 EUR (4) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.722 EUR (6) |
| YTD High | date | 3.079 EUR (2024/01/09) |
| YTD Low | date | 2.055 EUR (2024/04/04) |
| 52 Weeks High | date | 3.795 EUR (2023/11/23) |
| 52 Weeks Low | date | 2.055 EUR (2024/04/04) |
All listings for AVANTIUM NV
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/07/17 | 12:40 | 2.52 EUR | 0.00 | 7 |
| Duesseldorf | 2024/07/17 | 09:10 | 2.505 EUR | 0.00 | 2 |
| Euronext Amsterdam | 2024/07/17 | 12:20 | 2.525 EUR | 0.16 | 86 |
| FINRA other OTC Issues | 2024/07/11 | 21:05 | 2.52 USD | 0.01 | 3 |
| Frankfurt | 2024/07/17 | 11:30 | 2.50 EUR | 0.00 | 3 |
| London Stock Exchange | 2024/07/02 | 15:33 | 2.5325 EUR | 0.01 | 1 |
| Munich | 2024/07/17 | 08:18 | 2.525 EUR | 0.00 | 1 |
| Stuttgart | 2024/07/17 | 08:03 | 2.53 EUR | 0.00 | 1 |
| Tradegate | 2024/07/16 | 22:26 | 2.55 EUR | 0.00 | 6 |
Company Logo
Contact Details
| AVANTIUM NV |
| - - |
| Zekeringstraat 29 - 1014 BV Amsterdam |
| Telefon: +31-20-586-80-80 |
| Fax: +31-20-586-80-85 |
| E-mail: info@avantium.com |
PDF Downloads
| Company report: AVANTIUM NV | |
Company Profile
Avantium NV engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development. It operates through the following segments: R&D Solutions, Renewable Chemistries, and Renewable Polymers. The R&D Solutions segment provides advanced catalysis research and development services, systems, and testing to global customers. The Renewable Chemistries segment develops PlantMEG, a plant-based alternative for fossil-based mono-ethylene glyco. The Renewable Polymers segment focuses on the commercialization of YXY plants-to-plastics technology. The company was founded February 2000 and is headquartered in Amsterdam, the Netherlands. |
Members of Management Board
| Tom van Aken | Chairman of Managing Board |
| Boudewijn van Schaik | Member of Executive Committee |
Board of directors
| Edwin Moses | Chairman of Supervisory Board |
| Dirk van Meirvenne | Member of Supervisory Board |
| Margret Kleinsman | Member of Supervisory Board |
| Michelle Jou | Member of Supervisory Board |
| Nils Björkman | Member of Supervisory Board |
| Peter Williams | Member of Supervisory Board |